ML385 Attenuates Malignant Progression of Silica-induced Lung Adenocarcinoma Cells through the ROS/NRF2-autophagy

Yanhong Cao1, Wubi Zhou2, Junwen Cai3

  • 1School of Medicine, Anhui University of Science and Technology; Department of Medical Laboratory, Huaian Hospital of Huaian City.

Insights

Silica exposure promotes lung adenocarcinoma by affecting NRF2 and autophagy. The NRF2 inhibitor ML385 reverses these malignant changes, offering a potential therapeutic strategy for silica-related lung cancer.

Area of Science:

  • * Environmental Health
  • * Molecular Biology
  • * Cancer Research

Background:

  • * Silica exposure is linked to lung adenocarcinoma, but the underlying molecular mechanisms are not fully understood.
  • * The nuclear factor erythroid 2-related factor 2 (NRF2) pathway and autophagy are implicated in cancer progression and response to environmental toxins.
  • * Understanding these pathways is crucial for developing targeted therapies against silica-induced lung cancer.

Purpose of the Study:

  • * To establish a repeatable experimental protocol for investigating silica-induced lung adenocarcinoma.
  • * To explore the inhibitory effect of the NRF2 inhibitor ML385 on malignant progression.
  • * To elucidate the role of the ROS/NRF2-autophagy axis in silica-induced lung cancer.

Main Methods:

  • * Establishment of a silicosis mouse model via intranasal silica perfusion.
  • * In vitro studies using RAW264.7 macrophages treated with silica and ML385.
  • * Analysis of pulmonary fibrosis, immune cell infiltration, protein expression (NRF2, CDK1, VDAC1), autophagic flux, ROS levels, and lung adenocarcinoma cell migration, invasion, and apoptosis.

Main Results:

  • * Silica induced pulmonary fibrosis, immune cell infiltration, and upregulated NRF2, CDK1, and VDAC1 in mice.
  • * Silica inhibited macrophage autophagic flux and reduced ROS levels.
  • * ML385 treatment reversed silica-induced changes, inhibiting malignant progression in lung adenocarcinoma cells.

Conclusions:

  • * The established protocol provides a comprehensive approach for studying silica-related lung adenocarcinoma.
  • * The ROS/NRF2-autophagy axis is a key pathway in silica-induced lung cancer progression.
  • * ML385 demonstrates potential as a therapeutic agent targeting NRF2 for silica-induced lung adenocarcinoma.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.6K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.1K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.9K